DarioHealth (NSDQ:DRIO) said today that the Lightning-enabled version of its blood glucose monitoring system is available in Australia.

The device is designed to connect with the latest Apple products, including the iPhone 7, iPhone 8 and iPhone X. The product’s launch comes just one month after it won approval from Australian authorities.

Israel-based DarioHealth reported that Apple iOS has more than 55% market share in Australia.

“We are happy to confirm that we are recommitting ourselves to the Australian market. Over the past few months, we have been working tirelessly to get the TGA (Therapeutic Goods Administration) Mark so we can cater to the Australian market and help people with diabetes to manage their disease with the most up-to-date technology Dario has to offer,” chairman & CEO Erez Raphael said in prepared remarks.

“We look forward to continuing our mission of simplifying diabetes management in all of our markets globally.”

The Dario Lightning-enabled device also launched in the U.K. this month. Next up for the company’s blood glucose monitoring system is the German market, according to DarioHealth.

The company’s Lightning-enabled product is still being reviewed by the FDA in the U.S., but DarioHealth said it expects to hear back from the regulatory agency over the next few months.

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.